| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500623 | Farmacia Hospitalaria | 2006 | 8 Pages |
Abstract
There is a high percentage of therapy failures and inconsistency between erythropoietin use recommendations and clinical practice. This circumstance, as well as the high financial impact it entails, makes it essential that monitoring and follow- up strategies are implemented to contribute to an optimal usage of erythropoiesis stimulating factors.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
A. Pelufo Pellicer, E. Monte Boquet, J.L. Poveda Andrés, M.J. Cuéllar Monreal,